| Pharmaceutical active ingredients: |
| Isosorbide Mononitrate |
| Available forms, composition and doses of Monit-Puren Retard: |
| Tablets, Retard; Oral; Isosorbide Mononitrate 40 mgTablets, Retard; Oral; Isosorbide Mononitrate 60 mg |
| Monit-Puren Retard medical category: |
| Human:Anti-anginal drugsNitrates and nitrites |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C01DA14 - Isosorbide Mononitrate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Alpharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Monit | Isosorbide Mononitrate | Sanofi-Aventis; Intas Pharmaceuticals |
| Monitan | Acebutolol Hydrochloride | Wyeth |
| Monit-AS | Aspirin; Isosorbide Mononitrate | Intas Pharmaceuticals |
| Monite | Hydroxyapatite | Unidentified Pharmaceutical Company |
| Monit-Puren | Isosorbide Mononitrate | Alpharma |
| Monizid | Isosorbide Mononitrate | Unidentified Pharmaceutical Company |
| Monizol | Miconazole Nitrate | Krolton Labopharma Pharmaceutical Group |
| Monizol Cort | Hydrocortisone; Metronidazole; Miconazole Nitrate | Krolton Labopharma Pharmaceutical Group |
| Monizol Cort Crema | Betamethasone Valerate; Gentamicin Sulfate; Miconazole | Krolton Labopharma Pharmaceutical Group |
| Monizole | Metronidazole | The Pharmaceutical Company of India |